Artelo Stock Analysis


USD 3.26  0.07  2.19%   

The new Artelo Biosciences price pull down could raise concerns from stakeholders as the firm is trading at a share price of 3.26 on 15,200 in volume. The company directors and management were unable to exploit market volatilities in August. However, diversifying your overall positions with Artelo Biosciences can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 8.19. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Artelo Biosciences partners.
Please continue to Trending Equities.
The Artelo Biosciences stock analysis report makes it easy to digest most publicly released information about Artelo Biosciences and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Artelo Stock analysis module also helps to analyze the Artelo Biosciences price relationship with some important fundamental indicators such as market cap and management efficiency.

Artelo Stock Analysis Notes

The company recorded a loss per share of 0.6. Artelo Biosciences had not issued any dividends in recent years. The entity had 15.00 - 1.00 split on the 10th of August 2022. Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California. Artelo Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. For more info on Artelo Biosciences please contact the company at 858 925 7049 or go to

Artelo Biosciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Artelo Biosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Artelo Biosciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Artelo Biosciences generated a negative expected return over the last 90 days
Artelo Biosciences has high historical volatility and very poor performance
The company reported the previous year's revenue of 212.82 M. Net Loss for the year was (12.38 M) with profit before overhead, payroll, taxes, and interest of 83.01 M.
Artelo Biosciences currently holds about 23.51 M in cash with (8.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.56.
Latest headline from MacroaxisInsider: Artelo Biosciences exotic insider transaction detected

Artelo Biosciences Upcoming and Recent Events

Earnings reports are used by Artelo Biosciences to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Artelo Biosciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report12th of April 2022
Next Financial Report11th of July 2022
Next Fiscal Quarter End28th of February 2022
Next Fiscal Year End5th of December 2022
Last Quarter Report30th of November 2021
Last Financial Announcement28th of February 2021

Artelo Biosciences SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Artelo Biosciences prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Artelo Biosciences investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Artelo Biosciences specific information freely available to individual and institutional investors to make a timely investment decision.
16th of September 2022
Submission of Matters to a Vote of Security Holders. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year
25th of August 2022
Other Events
9th of August 2022
Financial Statements and Exhibits. Other Events. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year. Material Modifications to Rights of Security Holders
12th of July 2022
Submission of Matters to a Vote of Security Holders
16th of May 2022
Financial Statements and Exhibits. Unregistered Sales of Equity Securities. Entry into a Material Definitive Agreement
16th of March 2022
Other Events
9th of March 2022
Financial Statements and Exhibits. Other Events. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
23rd of February 2022
Unclassified Corporate Event

Artelo Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Artelo Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Artelo Biosciences backward and forwards among themselves. Artelo Biosciences' institutional investor refers to the entity that pools money to purchase Artelo Biosciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares683.9 K217 K
Verition Fund Management LlcWarrants35 K166 K
Geode Capital Management LlcCommon Shares187.1 K59 K
Snowden Capital Advisors LlcCommon Shares110 K34 K
Bank Of New York Mellon CorpCommon Shares86 K27 K
Susquehanna International Group LlpCommon Shares80.1 K25 K
Virtu Financial LlcCommon Shares63.2 K20 K
Northern Trust CorpCommon Shares62.5 K20 K
Note, although Artelo Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Artelo Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 134.94 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Artelo Biosciences's market, we take the total number of its shares issued and multiply it by Artelo Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (27.75) % which means that it has lost $27.75 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (45.8) %, meaning that it created substantial loss on money invested by shareholders. Artelo Biosciences management efficiency ratios could be used to measure how well artelo biosciences manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 28th of September, Artelo Biosciences shows the risk adjusted performance of (0.03362), and Mean Deviation of 4.53. Artelo Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Artelo Biosciences, which can be compared to its rivals. Please confirm Artelo Biosciences variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Artelo Biosciences is priced correctly, providing market reflects its regular price of 3.26 per share. Given that Artelo Biosciences has jensen alpha of (0.17), we suggest you to validate Artelo Biosciences's prevailing market performance to make sure the company can sustain itself at a future point.

Artelo Biosciences Price Movement Analysis

The output start index for this execution was thirty-four with a total number of output elements of twenty-seven. The Weighted Moving Average calculates a weight for each value in Artelo Biosciences price series with the more recent values given greater weights.

Artelo Biosciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Artelo Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Artelo Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Artelo Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Artelo Biosciences Predictive Daily Indicators

Artelo Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Artelo Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Artelo Biosciences Forecast Models

Artelo Biosciences time-series forecasting models is one of many Artelo Biosciences' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Artelo Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Artelo Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Artelo Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Artelo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Artelo Biosciences. By using and applying Artelo Stock analysis, traders can create a robust methodology for identifying Artelo entry and exit points for their positions.
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California. Artelo Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.

Current Artelo Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Artelo analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Artelo analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
4.67Strong Buy3Odds
Artelo Biosciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Artelo analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Artelo stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Artelo Biosciences, talking to its executives and customers, or listening to Artelo conference calls.
Artelo Analyst Advice Details

Artelo Stock Analysis Indicators

Artelo Biosciences stock analysis indicators help investors evaluate how Artelo Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Artelo Biosciences shares will generate the highest return on investment. By understating and applying Artelo Biosciences stock analysis, traders can identify Artelo Biosciences position entry and exit signals to maximize returns.
Shares Percent Shares Out2.09%
Quick Ratio26.87
Fifty Two Week Low3.1100
Short Percent Of Float2.10%
Forward Price Earnings-12.76
Float Shares41.94M
Fifty Two Week High19.8000
Shares Short Prior Month843.27k
Average Daily Volume Last 10 Day58.63k
Average Daily Volume In Three Month338.71k
Fifty Day Average4.5019
Two Hundred Day Average5.7622
Please continue to Trending Equities. You can also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for analysis

When running Artelo Biosciences price analysis, check to measure Artelo Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artelo Biosciences is operating at the current time. Most of Artelo Biosciences' value examination focuses on studying past and present price action to predict the probability of Artelo Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Artelo Biosciences' price. Additionally, you may evaluate how the addition of Artelo Biosciences to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Transaction History
View history of all your transactions and understand their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Is Artelo Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Artelo Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.